Absci (ABSI) stock Forecast for 2022 – 2026
Last update: October 6, 2022 (06:54)Sector: Healthcare
The share price of Absci Corporation (ABSI) now
What analysts predict: $13.1
52-week high/low: $18.12 / $2.9
50/200 Day Moving Average: $3.762 / $5.71
This figure corresponds to the average price over the previous 50/200 days. For Absci stocks, the 50-day moving average is the resistance level today.
For Absci stocks, the 200-day moving average is the resistance level today.
Are you interested in Absci Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Absci stock price in 2022, 2023, 2024, 2025, 2026. How much will one Absci share be worth in 2022 - 2026?
When should I take profit in Absci stock? When should I record a loss on Absci stock? What are analysts' forecasts for Absci stock? What is the future of Absci stock?
We forecast Absci stock performance using neural networks based on historical data on Absci stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Absci stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Absci shares. This happens once a day.
Fresh insight into Absci stockView all analytics
Summary Absci, a Vancouver-based drug discovery company that IPOd in July last year, has seen its market cap fall from >$2bn, to $665m at the time of writing. This isn’t … Read more
Summary Absci, a synthetic biology company whose platform technology aids in the drug discovery process, is going public today. CEO Sean McClain discusses the emotion around going public, acquisitions in … Read more
Historical and forecast chart of Absci stock
The chart below shows the historical price of Absci stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Absci stock price can be found in the table below.
Long-term forecasts by years.
Absci daily forecast for a month
Absci Daily Price Targets
Absci Stock Forecast 10-08-2022.
Pessimistic target level: 3.04
Optimistic target level: 3.19
Absci Stock Forecast 10-09-2022.
Pessimistic target level: 3.02
Optimistic target level: 3.23
Absci Stock Forecast 10-10-2022.
Pessimistic target level: 2.94
Optimistic target level: 3.16
Absci Stock Forecast 10-11-2022.
Pessimistic target level: 2.78
Optimistic target level: 2.97
Absci Stock Forecast 10-12-2022.
Pessimistic target level: 2.74
Optimistic target level: 2.89
Absci Stock Forecast 10-13-2022.
Pessimistic target level: 2.88
Optimistic target level: 3.02
ABSI (ABSI) Monthly Stock Prediction for 2022
Absci forecast for this year
Absci Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $2.97882. Pessimistic: $2.60. Optimistic: $3.33
Absci Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $2.91627. Pessimistic: $2.60. Optimistic: $3.27
Absci (ABSI) Monthly Stock Prediction for 2023
Absci (ABSI) Monthly Stock Prediction for 2024
Absci (ABSI) Monthly Stock Prediction for 2025
Absci (ABSI) Monthly Stock Prediction for 2026
Absci information and performance
Absci Corporation, an artificial intelligence-powered synthetic biology company, offers candidate biologics and production cell lines using an integrated drug discovery platform for partners in the United States. Its integrated drug discovery platform enables biologics to be created by integrating drug discovery and cell line development into a single process. The company was founded in 2011 and is headquartered in Vancouver, Washington.
18105 SE MILL PLAIN BLVD, VANCOUVER, WA, US
Market Capitalization: 290 600 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -93 164 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.376
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 20.91
Enterprise Value (EV) /Revenue
EV To EBITDA: -1.037
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 92844000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.